In this issue:
- IPF mortality, incidence and prevalence in Australia
- Best IPF care in Australia
- Frailty in ILD
- Hypoxaemia in fibrotic ILD
- Inhaled RVT-1601 for chronic cough in IPF
- Tocilizumab for early systemic sclerosis-ILD
- Lung function changes predict mortality in fibrotic hypersensitivity pneumonitis
- Lung function trajectory in progressive fibrosing ILD
- K-BILD in progressive fibrosing ILD
- Proteomic biomarkers of progressive fibrosing ILD
- Cyclophosphamide + glucocorticoids in acute IPF exacerbation
- Lung microenvironments and fibrotic hypersensitivity pneumonitis progression
- Alveolar crystal burden in artificial stone silicosis workers
- When to start palliative care in progressive fibrotic ILD
Please login below to download this issue (PDF)